What is CYRX's market cap?

$845.84M, based on the Nov 4 close of $16.70.

Does CryoPort pay a dividend?

No regular cash dividend has been paid in the last year.

How much of CYRX is sold short?

2.5M shares, 5.3% of float, as of Oct 15, 2026.

What sector is CYRX in?

Healthcare, in the Pharmaceuticals industry.

NASDAQ · CYRXHealthcarePharmaceuticals

CryoPort, Inc. Common Stock (CYRX)

$16.70+1.52%

Close Nov 4, 2026 · split-adjusted

Nov 3, 2026$16.45▲ 81.97% in range

Nov 3, 2025Low $7.72 · High $18.64Nov 3, 2026

What changed · written from our data

As of Nov 4, 2026

CryoPort closed at $16.70 on Nov 4, up 1.52%, 10.4% below its 52-week closing high. Volume of 1.3M shares was 1.36× its 20-day average (above normal).

Split-adjusted performance: -6.2% over one month, +31.6% over six months, +84.7% over one year.

In the quarter ended Jun 30, 2026, revenue was $48.97M, up 7.7% from a year earlier, with a net margin of -20.9%.

Short interest was 2.5M shares at the Oct 15 settlement, up 7.2% from the prior report (5.3% of float, 3.1 days to cover).

Market cap$845.8M50.6M shares

Revenue · quarter$49.0M+7.7% YoY

Diluted EPS$-0.20−109.4% YoY

P/E · TTM—P/S 4.5×

Net margin-20.9%Gross 46.6%

Dividend yieldNone

52-week range7.72 – 18.64−10.4% from high

Volume1.3M1.36× 20-day avg

Volatility · 60d40.3%Annualised

Short % of float5.3%3.1 days to cover

Net cash$208.7MCash $396.7M

Next earnings—Not scheduled

Split-adjusted performance

1W −10.4%1M −6.2%3M +13.5%6M +31.6%YTD +74.0%1Y +84.7%3Y +78.8%5Y −78.5%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Pharmaceuticals

Percentile among 420 companies (100 = best)

6-month momentum87

Revenue growth53

Net margin55

Value (low P/E)—

Size68

Industry medians: 6-month return −25.5%, revenue growth +6.2%, net margin −33.8%, P/E 16.1×.

Short interest

Details →

Shares short2.5M+7.2% vs prior

Days to cover3.1Settled Oct 15

% of float5.3%

Short vol. 10d36.5%of daily volume

Closest peers by size in Pharmaceuticals

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
CYRXCryoPort	$16.70	+1.52%	+31.6%	+7.7%	−20.9%	—	$845.8M
AKTSAktis Oncology	$15.20	+1.74%	−24.1%	—	−713.5%	—	$845.4M	Compare
ALMSAlumis	$6.55	+0.77%	−74.3%	−37.7%	−8557.2%	—	$847.8M	Compare
ARDXArdelyx	$3.29	+8.58%	−53.7%	+15.7%	−0.6%	—	$849.4M	Compare
ANNXAnnexon	$4.33	+3.34%	−24.0%	—	—	—	$820.9M	Compare
CRVSCorvus Pharmaceuticals	$10.57	+7.53%	−31.6%	—	—	—	$889.2M	Compare
ABUSArbutus Biopharma	$4.06	+4.64%	−8.1%	−90.6%	−512.0%	5.3	$804.3M	Compare
ANROAlto Neuroscience	$23.30	+2.64%	−4.9%	—	—	—	$914.3M	Compare
COLLCollegium Pharmaceutical	$23.67	−0.25%	−35.2%	+6.3%	−7.5%	16.1	$770.6M	Compare

News about CryoPort

All news →

Is CryoPort (CYRX) Outperforming Other Medical Stocks This Year?Zacks Investment Research · Oct 1, 2026▲ Positive Cryoport Reports First Quarter 2026 Financial ResultsBenzinga · May 4, 2026▲ Positive Cryoport's MVE Biological Solutions Introduces New Fusion® 800 SeriesBenzinga · Feb 11, 2026▲ Positive

Quick answers

What does CryoPort do?: CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing.
What is CYRX's market cap?: $845.84M, based on the Nov 4 close of $16.70.
Does CryoPort pay a dividend?: No regular cash dividend has been paid in the last year.
How much of CYRX is sold short?: 2.5M shares, 5.3% of float, as of Oct 15, 2026.
What sector is CYRX in?: Healthcare, in the Pharmaceuticals industry.

About CryoPort

CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.

HQ: Brentwood, TN738 employeesListed Jul 16, 1993cryoportinc.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology